Dexycu
Product Images NDC 71879-001

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Dexycu (NDC 71879-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eyepoint Pharmaceuticals Us, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Dexycu 01)

Packaging and contents of Dexycu (dexamethasone intraocular suspension) 9% single-dose vial. The image shows the Dexycu vial along with a syringe and several administration accessories. The label indicates a 0.005 mL dose for intraocular use. Labeler is EyePoint Pharmaceuticals US, Inc.*

FDA Label Image

Figure (Dexycu 02)

An illustrated diagram showing components of an injection system for Dexycu. The image includes a syringe with measurement markings, two separate needle caps or hub components, and a needle with a separate protective cover. The arrangement appears to detail assembly or parts included for administration of the injectable product by EyePoint Pharmaceuticals US, Inc.*

FDA Label Image

Figure (Dexycu 03)

An instructional illustration showing two syringes, each with an attached plastic component. The diagram includes arrows indicating steps or parts being connected or aligned on the syringes, likely demonstrating a preparation or assembly process related to the product Dexycu by EyePoint Pharmaceuticals US, Inc.*

FDA Label Image

Figure (Dexycu 04)

An instructional diagram showing a syringe and needle assembly likely related to the administration of Dexycu. The image depicts the needle detached from the syringe with arrows indicating the steps for attaching or detaching the components.*

FDA Label Image

Figure (Dexycu 05)

Illustration showing a vial labeled Dexycu with arrows indicating the direction to twist or open the vial cap. The image likely demonstrates how to open the Dexycu vial for use.*

FDA Label Image

Figure (Dexycu 06)

An illustration showing a vial labeled Dexycu with a separate vial cap above it, accompanied by arrows indicating the cap is to be placed on or removed from the vial. The image suggests vial opening or closing instructions for the product Dexycu.*

FDA Label Image

Figure (Dexycu 07)

An illustration showing a small vial labeled 'Dexycu' connected to a syringe with a needle. The image depicts the preparation or drawing of the Dexycu medication from the vial into the syringe, likely for injection purposes.*

FDA Label Image

Figure (Dexycu 08)

An instructional diagram showing two steps of a syringe assembly: one image depicts a needle being pulled upward off a syringe, and the other shows a needle being pushed downward onto a syringe, indicating how to attach or detach the needle.*

FDA Label Image

Figure (Dexycu 09)

An instructional diagram showing a syringe with its plunger and barrel. Two downward arrows indicate the direction for attaching or pressing a component onto the syringe. The image appears to demonstrate syringe use or assembly steps.*

FDA Label Image

Figure (Dexycu 10)

An instructional diagram showing a close-up view of a syringe, highlighting a part near the plunger with an arrow pointing to a specific feature. The illustration likely indicates a step in the preparation or administration process for Dexycu by EyePoint Pharmaceuticals.*

FDA Label Image

Figure (Dexycu 11)

An instructional illustration showing a syringe with a needle, featuring a plunger with arrows indicating an upward pulling motion. This likely demonstrates how to prepare or use the syringe for administration.*

FDA Label Image

Figure (Dexycu 12)

An anatomical line drawing of a human eye focused on the anterior segment, illustrating placement related to the Dexycu ophthalmic product by EyePoint Pharmaceuticals US, Inc. The image highlights the front part of the eye and the area beneath the iris, likely indicating the site of product application or action.*

FDA Label Image

Chemical Structure (Dexycu 13)

Chemical structure diagram of the active ingredient in Dexycu, depicting its steroidal framework with functional groups including hydroxyl, carbonyl, and fluorine substitutions.*

FDA Label Image

Principal Display Panel (0.005 mL Vial Carton)

The image shows the packaging label for Dexycu, a 9% dexamethasone intraocular suspension in a 0.005 mL single dose vial for intraocular administration. The label includes the product name, active ingredient with concentration, dosage form, and manufacturer EyePoint Pharmaceuticals US, Inc, along with the NDC 71879-001. The design features a pattern of purple and pink dots and storage information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.